Home › Biblio

Biblio

Found 24 results

2010
Watkins PA, Moser AB, Toomer CB, Steinberg SJ, Moser HW, Karaman MW, Ramaswamy K, Siegmund KD, Lee RD, Ely JJ et al..  2010.  Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions.. BMC physiology. 10:19. Abstract
2009
Smith SA, Golay X, Fatemi A, Mahmood A, Raymond GV, Moser HW, van Zijl PCM, Stanisz GJ.  2009.  Quantitative magnetization transfer characteristics of the human cervical spinal cord in vivo: application to adrenomyeloneuropathy.. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 61(1):22-7. Abstract
2008
Pillion JP, Moser HW, Raymond GV.  2008.  Auditory function in adrenomyeloneuropathy.. Journal of the neurological sciences. 269(1-2):24-9. Abstract
2007
Moser HW, Moser AB, Hollandsworth K, Brereton HN, Raymond GV.  2007.  "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.. Journal of molecular neuroscience : MN. 33(1):105-13. Abstract
Moser HW, Mahmood A, Raymond GV.  2007.  X-linked adrenoleukodystrophy.. Nature clinical practice. Neurology. 3(3):140-51. Abstract
Mahmood A, Raymond GV, Dubey P, Peters C, Moser HW.  2007.  Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study.. Lancet neurology. 6(8):687-92. Abstract
2006
Cox CS, Dubey P, Raymond GV, Mahmood A, Moser AB, Moser HW.  2006.  Cognitive evaluation of neurologically asymptomatic boys with X-linked adrenoleukodystrophy.. Archives of neurology. 63(1):69-73. Abstract
Zackowski KM, Dubey P, Raymond GV, Mori S, Bastian AJ, Moser HW.  2006.  Sensorimotor function and axonal integrity in adrenomyeloneuropathy.. Archives of neurology. 63(1):74-80. Abstract
Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW.  2006.  Peroxisome biogenesis disorders.. Biochimica et biophysica acta. 1763(12):1733-48. Abstract
Moser HW.  2006.  Therapy of X-linked adrenoleukodystrophy.. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. 3(2):246-53. Abstract
2005
Dubey P, Fatemi A, Huang H, Nagae-Poetscher L, Wakana S, Barker PB, van Zijl P, Moser HW, Mori S, Raymond GV.  2005.  Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy.. Annals of neurology. 58(5):758-66. Abstract
Moser HW, Raymond GV, Lu S-E, Muenz LR, Moser AB, Xu J, Jones RO, Loes DJ, Melhem ER, Dubey P et al..  2005.  Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.. Archives of neurology. 62(7):1073-80. Abstract
Smith SA, Golay X, Fatemi A, Jones CK, Raymond GV, Moser HW, van Zijl PCM.  2005.  Magnetization transfer weighted imaging in the upper cervical spinal cord using cerebrospinal fluid as intersubject normalization reference (MTCSF imaging).. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 54(1):201-6. Abstract
Moser HW, Raymond GV, Dubey P.  2005.  Adrenoleukodystrophy: new approaches to a neurodegenerative disease.. JAMA : the journal of the American Medical Association. 294(24):3131-4. Abstract
Mahmood A, Dubey P, Moser HW, Moser A.  2005.  X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.. Pediatric transplantation. 9 Suppl 7:55-62. Abstract
Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW.  2005.  Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening.. The Journal of pediatrics. 146(4):528-32. Abstract
2004
Moser HW, Fatemi A, Zackowski K, Smith S, Golay X, Muenz L, Raymond G.  2004.  Evaluation of therapy of X-linked adrenoleukodystrophy.. Neurochemical research. 29(5):1003-16.
Moser HW.  2004.  Genetic causes of mental retardation.. Annals of the New York Academy of Sciences. 1038:44-8. Abstract
2003
Pizzini F, Fatemi AS, Barker PB, Nagae-Poetscher LM, Horská A, Zimmerman AW, Moser HW, Bibat G, Naidu S.  2003.  Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease.. AJNR. American journal of neuroradiology. 24(8):1683-9. Abstract
Moser HW, Raymond GV, Koehler W, Sokolowski P, Hanefeld F, Korenke GC, Green A, Loes DJ, Hunneman DH, Jones RO et al..  2003.  Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.. Advances in experimental medicine and biology. 544:369-87.
2002
Eichler FS, Itoh R, Barker PB, Mori S, Garrett ES, van Zijl PCM, Moser HW, Raymond GV, Melhem ER.  2002.  Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience.. Radiology. 225(1):245-52. Abstract
Mori S, Kaufmann WE, Davatzikos C, Stieltjes B, Amodei L, Fredericksen K, Pearlson GD, Melhem ER, Solaiyappan M, Raymond GV et al..  2002.  Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking.. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 47(2):215-23. Abstract
Tagawa Y, Laroy W, Nimrichter L, Fromholt SE, Moser AB, Moser HW, Schnaar RL.  2002.  Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids.. Neurochemical research. 27(7-8):847-55. Abstract
Villemagne PM, Naidu S, Villemagne VL, Yaster M, Wagner HN, Harris JC, Moser HW, Johnston MV, Dannals RF, Wong DF.  2002.  Brain glucose metabolism in Rett Syndrome.. Pediatric neurology. 27(2):117-22. Abstract

Your Support is the Key

Submitted by admin on May 9, 2011 - 11:20am

Matthew Slattery

Help children like Matthew unlock their potential by becoming a Partner in Potential.

Donate Learn More